跳至主要内容
临床试验/NCT01510691
NCT01510691撤回不适用

The Influence of Retinal Oxygenation on the Clinical Outcomes in Eyes With Different Vitreoretinal Pathologies After a Successful Vitrectomy

Stefan Sacu1 个研究点 分布在 1 个国家开始时间: 2011年10月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Clinical Data

研究概览

简要总结

Vitrectomy is the common treatment for patients with macular edema secondary to epiretinal membrane. Recently, in eyes with diabetic macular edema or persistent macular edema following retinal vein occlusion, vitrectomy will be increasingly performed as an additional treatment modality. In eyes with impaired oxygen situation vitrectomy may improve the retinal oxygen saturation. However, little information is available about the oxygenation and the blood flow of the retinal vessels after vitroretinal surgery.

Hypoxia is a the major trigger of vascular endothelial growth factor (VEGF), which is in turn the most important factor for the development of macular edema. It is a major issue to improve the oxygen situation and the blood flow of the retina and there are just a few not satisfactory procedures available to overcome this problem. However, vitrectomy would be an adequate therapy for many of these diseases, and it would be an appreciated side effect of the treatment in almost every case.

To investigate the influence of oxygenation and blood flow of the retina on clinical outcomes after a successfully 23 gauge vitrectomy in eyes with epiretinal membrane, persistent macular edema following diabetic retinopathy or retinal vein occlusion.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male or female, at least 18 years of age.
  • ophthalmoscopic evidence of epiretinal membrane scheduled for vitrectomy and membrane peeling.
  • persistent diabetic macular edema
  • written informed consent
  • female patients of childbearing potential must have a negative urine pregnancy test.

排除标准

  • uncontrolled systemic disease
  • symptoms of a clinically relevant illness in the 3 weeks before the first study day
  • any ocular condition that in the opinion of the investigator would be a contraindication for the surgical procedure
  • history of glaucoma, aphakie or presence of anterior chamber intraocular lens, choroidal neovascularisation, significant cataract, any ocular infection, - history of pars plana vitrectomy.
  • contraindication to pupil dilation.
  • need for silicon oil or gas after the surgery
  • advanced diabetic retinopathy with vitreoretinal tear and/or bleeding

结局指标

主要结局

Clinical Data

时间窗: 6 months

Visus, OCT

Blood Flow Data

时间窗: 6 months

Oxygenation of retinal blood vessles and retinal blood flow

次要结局

未报告次要终点

研究者

发起方
Stefan Sacu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Stefan Sacu

Ass Prof Priv Doz Dr

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验

Vitrectomy Retinal Oxygenation | 临床试验